Literature DB >> 6410032

Gastrointestinal mast cells in health and disease. Part I.

R F Lemanske, F M Atkins, D D Metcalfe.   

Abstract

The mast cell granule provides three distinct sources of mediators: (1) preformed and rapidly released (histamine), (2) secondarily formed and generated by the interaction of primary mediators and nearby cells and tissues (leukotrienes), and (3) granule matrix-derived, which are preformed but remain associated with the granule proteoglycans after discharge (proteases) (Table). The granule matrix and its associated mediators may remain in the tissue for hours until removed through degradation, dissolution, or phagocytosis. The events initiated by the mediators depend on the tissues into which they are released. Mediator discharge clearly initiates the events associated with immediate hypersensitivity; however, late-phase reactions occur in response to granule-derived mediators as well. Several manifestations that may result from the introduction of mast cell-derived products within the gastrointestinal tract are shown in Fig. 5. These include increased vascular permeability and secretion of mucus, effects on cell surface receptors, chemotaxis of various cell types, and smooth muscle contraction. Thus the mast cell, because of its unique anatomic location and mediators, may serve both as an initiator of acute inflammation and a propagator of chronic changes as well.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6410032     DOI: 10.1016/s0022-3476(83)80341-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  7 in total

1.  Gastric inflammation during systemic anaphylaxis: neutrophil recruitment in stomach wall of mice does not require mast cell participation.

Authors:  G T Furuta; Z S Wang; B K Wershil
Journal:  Dig Dis Sci       Date:  1998-09       Impact factor: 3.199

2.  Passive sensitization of human intestinal mast cells.

Authors:  H Nolte; A Kruse; P Stahl Skov; P O Schiøtz
Journal:  Agents Actions       Date:  1989-04

3.  Histamine release from gut mast cells from patients with inflammatory bowel diseases.

Authors:  H Nolte; N Spjeldnaes; A Kruse; B Windelborg
Journal:  Gut       Date:  1990-07       Impact factor: 23.059

4.  Ultrastructure of cerebellar capillary hemangioblastoma. II. Mast cells and angiogenesis.

Authors:  K L Ho
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

5.  Localized gut-associated lymphoid tissue hemorrhage induced by intravenous peptidoglycan-polysaccharide polymers.

Authors:  R B Sartor; S K Anderle; W J Cromartie; J H Schwab
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

6.  Effects of somatostatin on ethanol-induced gastric erosions in the rat: role of mast cells.

Authors:  F Diel; H Borck; S Hosenfeld
Journal:  Agents Actions       Date:  1986-04

7.  IL-4-producing ILC2s are required for the differentiation of TH2 cells following Heligmosomoides polygyrus infection.

Authors:  V S Pelly; Y Kannan; S M Coomes; L J Entwistle; D Rückerl; B Seddon; A S MacDonald; A McKenzie; M S Wilson
Journal:  Mucosal Immunol       Date:  2016-02-17       Impact factor: 7.313

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.